COLUMBUS, Ga. - February 5, 2025 - Aflac Incorporated (NYSE: AFL) today reported its fourth quarter results.

Total revenues were $5.4 billion in the fourth quarter of 2024, compared with $3.8 billion in the fourth quarter of 2023. Net earnings were $1.9 billion, or $3.42 per diluted share, compared with $268 million, or $0.46 per diluted share a year ago.

Net earnings in the fourth quarter of 2024 included net investment gains of $1.0 billion, or $1.86 per diluted share, compared with net investment losses of $511 million, or $0.87 per diluted share a year ago. These net investment gains were driven by net gains of $1.2 billion on certain derivatives and foreign currency activities; and a $40 million gain from an increase in the fair value of equity securities offset by $95 million of reserves for current expected credit losses (CECL); net losses from sales and redemptions of $74 million; and no impairments.

Adjusted earnings* in the fourth quarter were $865 million, compared with $732 million in the fourth quarter of 2023, reflecting an increase of 18.2%. Adjusted earnings per diluted share* increased 24.8% to $1.56 in the quarter. Variable investment income ran $17 million above the company's long-term return expectations. The weaker yen/dollar exchange rate negatively impacted adjusted earnings per share by $0.01.

The average yen/dollar exchange rate in the fourth quarter of 2024 was 152.35, or 2.8% weaker than the average rate of 148.11 in the fourth quarter of 2023. For the full year, the average exchange rate was 150.97, or 6.9% weaker than the rate of 140.57 a year ago.

Shareholders’ equity was $26.1 billion, or $47.45 per share, at December 31, 2024, compared with $22.0 billion, or $38.00 per share, at December 31, 2023. Shareholders’ equity at the end of the fourth quarter included a cumulative increase of $2.0 billion for the effect of the change in discount rate assumptions on insurance reserves, compared with a corresponding cumulative decrease of $2.6 billion at December 31, 2023 and a net unrealized gain on investment securities and derivatives of $4 million, compared with a net unrealized gain of $1.1 billion at December 31, 2023. Shareholders’ equity at the end of the fourth quarter also included an unrealized foreign currency translation loss of $5.0 billion, compared with an unrealized foreign currency translation loss of $4.1 billion at December 31, 2023. The annualized return on average shareholders’ equity in the fourth quarter was 29.9%.

For the full year of 2024, total revenues were up 1.2% to $18.9 billion, compared with $18.7 billion in the full year of 2023. Net earnings were $5.4 billion, or $9.63 per diluted share, compared with $4.7 billion, or $7.78 per diluted share, for the full year of 2023. Adjusted earnings for the full year of 2024 were $4.1 billion, or $7.21 per diluted share, compared with $3.7 billion, or $6.23 per diluted share, in 2023. Excluding the negative impact of $0.18 per share from the weaker yen/dollar exchange rate, adjusted earnings per diluted share increased 18.6% to $7.39 for the full year of 2024.

Shareholders’ equity excluding AOCI (or adjusted book value*) was $29.1 billion, or $52.87 per share at December 31, 2024, compared with $27.5 billion, or $47.55 per share, at December 31, 2023. Adjusted book value excluding foreign currency remeasurement* was $23.4 billion, or $42.46 per share, at December 31, 2024, compared with $23.8 billion, or $41.15 per share, at December 31, 2023. The annualized adjusted return on equity excluding foreign currency remeasurement* in the fourth quarter was 14.5%.

In yen terms, Aflac Japan's net earned premiums were ¥257.4 billion for the quarter, or 5.4% lower than a year ago, mainly due to internal cancer reinsurance transactions, as well as limited-pay policies reaching paid-up status. Adjusted net investment income increased 3.7% to ¥101.4 billion. Total adjusted revenues in yen declined 3.0% to ¥359.9 billion. Pretax adjusted earnings in yen for the quarter increased 1.0% on a reported basis to ¥113.8 billion, primarily due to lower benefits and expenses during the quarter, partially offset by lower net earned premiums. Pretax adjusted earnings decreased 1.1% on a currency-neutral basis. The pretax adjusted profit margin for the Japan segment increased to 31.6%, compared with 30.4% a year ago.

For the full year, net earned premiums in yen were ¥1.1 trillion, or 6.9% lower than a year ago. Adjusted net investment income increased 12.1% to ¥409.9 billion. Total adjusted revenues in yen were down 2.3% to ¥1.5 trillion. Pretax adjusted earnings were ¥527.7 billion, or 15.5% higher than a year ago.

In dollar terms, net earned premiums decreased 8.2% to $1.7 billion in the fourth quarter. Adjusted net investment income increased 1.5% to $665 million. Total adjusted revenues declined by 5.6% to $2.4 billion. Pretax adjusted earnings declined 1.1% to $0.7 billion.

For the full year, net earned premiums in dollars were $6.9 billion, or 13.9% lower than a year ago. Adjusted net investment income increased 4.6% to $2.7 billion. Total adjusted revenues were down 9.4% to $9.7 billion. Pretax adjusted earnings were $3.5 billion, or 8.0% higher than a year ago.

For the quarter, total new annualized premium sales (sales) increased 9.0% to ¥17.2 billion, or $113 million, primarily reflecting strong sales of Tsumitasu, the new first sector product. For the full year, total new sales increased 5.6% to ¥64.1 billion, or $422 million.

Aflac U.S. net earned premiums increased 2.7% to $1.4 billion in the fourth quarter compared to the prior year, reflecting prior year sales and continued improvement in persistency. Adjusted net investment income increased 0.9% to $213 million. Total adjusted revenues were up 2.0% to $1.7 billion. Pretax adjusted earnings were $330 million, 9.3% higher than a year ago, reflecting higher premiums and lower expenses which were partially offset by higher benefits. As a result, the pretax adjusted profit margin for the U.S. segment was 19.7%, compared with 18.4% a year ago.

For the full year, net earned premiums increased 2.7% to $5.8 billion. Adjusted net investment income increased 3.3% to $847 million. Total adjusted revenues were up 1.8% to $6.7 billion. Pretax adjusted earnings were $1.4 billion, or 5.5% lower than a year ago.

Aflac U.S. sales decreased 4.5% in the quarter to $534 million, reflecting lower sales of group voluntary benefit products impacted by our continued focus on profitable growth as well as softer sales of network dental. For the full year, total new sales decreased 1.0% to $1.5 billion.

For the quarter, total adjusted revenues increased 273.7% to $284 million compared to the prior year. The increase was primarily driven by higher adjusted net investment income due to a lower volume of tax credit investments and an increase due to reinsurance activity, which also increased total net earned premiums. Total benefits and adjusted expenses decreased $107 million compared to the prior year primarily due to the prior year novation of a reinsurance treaty with a third party that was ceded back to the company, partially offset by other reinsurance activity. Pretax adjusted earnings were a loss of $4 million, compared with a loss of $318 million a year ago.

For the full year, total adjusted revenues increased 118.9% to $1.0 billion. Pretax adjusted earnings were a gain of $32 million, compared with a loss of $425 million a year ago.

The board of directors declared the first quarter dividend of $0.58 per share, payable on March 3, 2025 to shareholders of record at the close of business on February 19, 2025.

In the fourth quarter, Aflac Incorporated deployed $750 million in capital to repurchase 7.0 million of its common shares. At the end of December 2024, the company had 47.3 million remaining shares authorized for repurchase.

Commenting on the company’s results, Aflac Incorporated Chairman and Chief Executive Officer Daniel P. Amos stated: "I am pleased that Aflac delivered very solid adjusted earnings for the quarter and the year. We have continued to actively concentrate on generating profitable growth in the U.S. and Japan with new products and distribution strategies. We believe our strategy will continue to create long-term value for shareholders.

"Looking at our operations in Japan, I am pleased with Aflac Japan’s 93.4% premium persistency and 5.6% year-over-year sales increase, which included a 9.0% sales increase in the fourth quarter. We have continued to focus on third sector products as well as introducing these policies to new and younger customers. Additionally, we were encouraged by the continued momentum of Tsumitasu, our latest life insurance product that offers an asset formation component and options such as nursing care. This approach is in line with our strategy of connecting with younger customers to provide them with integrated financial protection and services through different life stages.

"In the U.S., I continue to be pleased with our persistency results as we saw an increase to 79.3%, in addition to a 2.7% increase in net earned premiums. Sales were lower in the fourth quarter as we continue to focus on more profitable growth through our stronger underwriting discipline, in addition to re-engaging agents and brokers following stabilization of our network dental operations. We are seeing improvement in net earned premiums and continue our prudent approach to expense management and maintaining a strong pretax margin.

"We continue to generate strong capital and cash flows while maintaining our commitment to prudent liquidity and capital management. We have been very pleased with our investments, which have continued to produce strong net investment income. I am very pleased that 2024 marked 42 consecutive years of dividend increases, a record we treasure. We remain committed to extending this record, supported by our financial strength. We repurchased $2.8 billion in shares for the year. We intend to continue our balanced approach of investing in growth and driving long-term operating efficiencies."

*See Non-U.S. GAAP Financial Measures section for an explanation of foreign exchange and its impact on the financial statements and definitions of the non-U.S. GAAP financial measures used in this earnings release, as well as a reconciliation of such non-U.S. GAAP financial measures to the most comparable U.S. GAAP financial measures.

Aflac Incorporated (NYSE: AFL), a Fortune 500 company, has helped provide financial protection and peace of mind for nearly seven decades to millions of policyholders and customers through its subsidiaries in the U.S. and Japan. In the U.S., Aflac is the No. 1 provider of supplemental health insurance products.1 In Japan, Aflac Life Insurance Japan is the leading provider of cancer and medical insurance in terms of policies in force. The company takes pride in being there for its policyholders when they need us most, as well as being included in the World’s Most Ethical Companies by Ethisphere for 18 consecutive years (2024) and Fortune’s World’s Most Admired Companies for 23 years (2024). In addition, the company became a signatory of the Principles for Responsible Investment (PRI) in 2021 and has been included in the Dow Jones Sustainability North America Index (2024) for 11 years. To find out how to get help with expenses health insurance doesn't cover, get to know us at aflac.com or aflac.com/espanol. Investors may learn more about Aflac Incorporated and its commitment to corporate social responsibility and sustainability at investors.aflac.com under “Sustainability.”

1 LIMRA 2023 U.S. Supplemental Health Insurance Total Market Report

A copy of Aflac’s financial supplement for the quarter can be found on the “Investors” page at aflac.com.

Aflac Incorporated will webcast its quarterly conference call via the “Investors” page of aflac.com at 8:00 a.m. (ET) on February 6, 2025.

Note: Tables within this document may not foot due to rounding.

The company defines the non-U.S. GAAP financial measures included in this earnings release as follows:

•Adjusted earnings are adjusted revenues less benefits and adjusted expenses. Adjusted earnings per share (basic or diluted) are the adjusted earnings for the period divided by the weighted average outstanding shares (basic or diluted) for the period presented. The adjustments to both revenues and expenses account for certain items that are outside of management’s control because they tend to be driven by general economic conditions and events or are related to infrequent activities not directly associated with insurance operations. Adjusted revenues are U.S. GAAP total revenues excluding adjusted net investment gains and losses. Adjusted expenses are U.S. GAAP total acquisition and operating expenses including the impact of interest from derivatives associated with notes payable but excluding any non-recurring or other items not associated with the normal course of the Company’s insurance operations and that do not reflect the Company's underlying business performance. Management uses adjusted earnings and adjusted earnings per diluted share to evaluate the financial performance of the Company’s insurance operations on a consolidated basis and believes that a presentation of these financial measures is vitally important to an understanding of the underlying profitability drivers and trends of the Company’s insurance business. The most comparable U.S. GAAP financial measures for adjusted earnings and adjusted earnings per share (basic or diluted) are net earnings and net earnings per share, respectively.

•Adjusted earnings excluding current period foreign currency impact are computed using the average foreign currency exchange rate for the comparable prior-year period, which eliminates fluctuations driven solely by foreign currency exchange rate changes. Adjusted earnings per diluted share excluding current period foreign currency impact is adjusted earnings excluding current period foreign currency impact divided by the weighted average outstanding diluted shares for the period presented. The Company considers adjusted earnings excluding current period foreign currency impact and adjusted earnings per diluted share excluding current period foreign currency impact important because a significant portion of the Company's business is conducted in Japan and foreign exchange rates are outside management’s control; therefore, the Company believes it is important to understand the impact of translating foreign currency (primarily Japanese yen) into U.S. dollars. The most comparable U.S. GAAP financial measures for adjusted earnings excluding current period foreign currency impact and adjusted earnings per diluted share excluding current period foreign currency impact are net earnings and net earnings per share, respectively.

•Adjusted return on equity is annualized adjusted earnings divided by average shareholders’ equity, excluding accumulated other comprehensive income (AOCI). Management uses adjusted return on equity to evaluate the financial performance of the Company’s insurance operations on a consolidated basis and believes that a presentation of this financial measure is vitally important to an understanding of the underlying profitability drivers and trends of the Company’s insurance business. The Company considers adjusted return on equity important as it excludes components of AOCI, which fluctuate due to market movements that are outside management's control. The most comparable U.S. GAAP financial measure for adjusted return on equity is return on average equity (ROE) as determined using annualized net earnings and average total shareholders’ equity.

•Adjusted return on equity excluding foreign currency remeasurement is annualized adjusted earnings divided by average shareholders’ equity, excluding both AOCI and the cumulative [beginning January 1, 2021] foreign currency gains/losses associated with i) foreign currency remeasurement and ii) sales and redemptions of invested assets. The Company considers adjusted return on equity excluding foreign currency remeasurement important because it excludes both AOCI and the cumulative foreign currency remeasurement gains/losses, which fluctuate due to market movements that are outside management's control. The most comparable U.S. GAAP financial measure for adjusted return on equity excluding foreign currency remeasurement is return on average equity (ROE) as determined using annualized net earnings and average total shareholders’ equity.

•Amortized hedge costs/income represent costs/income incurred or recognized as a result of using foreign currency derivatives to hedge certain foreign exchange risks in the Company's Japan segment or in Corporate and other. These amortized hedge costs/income are estimated at the inception of the derivatives based on the specific terms of each contract and are recognized on a straight-line basis over the contractual term of the derivative. The Company believes that amortized hedge costs/income measure the periodic currency risk management costs/income related to hedging certain foreign currency exchange risks and are an important component of net investment income. There is no comparable U.S. GAAP financial measure for amortized hedge costs/income.

•Adjusted book value is the U.S. GAAP book value (representing total shareholders’ equity), less AOCI as recorded on the U.S. GAAP balance sheet. Adjusted book value per common share is adjusted book value at the period end divided by the ending outstanding common shares for the period presented. The Company considers adjusted book value and adjusted book value per common share important as they exclude AOCI, which fluctuates due to market movements that are outside management’s control. The most comparable U.S. GAAP financial measures for adjusted book value and adjusted book value per common share are total book value and total book value per common share, respectively.

•Adjusted book value excluding foreign currency remeasurement is the U.S. GAAP book value (representing total shareholders’ equity), less AOCI as recorded on the U.S. GAAP balance sheet and excluding the cumulative [beginning January 1, 2021] foreign currency gains/losses associated with i) foreign currency remeasurement and ii) sales and redemptions of invested assets. Adjusted book value excluding foreign currency remeasurement per common share is adjusted book value excluding foreign currency remeasurement at the period end divided by the ending outstanding common shares for the period presented. The Company considers adjusted book value excluding foreign currency remeasurement and adjusted book value excluding foreign currency remeasurement per common share important as they exclude both AOCI and the cumulative foreign currency remeasurement gains/losses, which fluctuate due to market movements that are outside management's control. The most comparable U.S. GAAP financial measures for adjusted book value excluding foreign currency remeasurement and adjusted book value excluding foreign currency remeasurement per common share are total book value and total book value per common share, respectively.

•Adjusted net investment income is net investment income adjusted for i) amortized hedge cost/income related to foreign currency exposure management strategies and certain derivative activity, and ii) net interest income/expense from foreign currency and interest rate derivatives associated with certain investment strategies, which are reclassified from net investment gains and losses to net investment income. The Company considers adjusted net investment income important because it provides a more comprehensive understanding of the costs and income associated with the Company’s investments and related hedging strategies. The most comparable U.S. GAAP financial measure for adjusted net investment income is net investment income.

•Adjusted net investment gains and losses are net investment gains and losses adjusted for i) amortized hedge cost/income related to foreign currency exposure management strategies and certain derivative activity, ii) net interest income/expense from foreign currency and interest rate derivatives associated with certain investment strategies, which are both reclassified to net investment income, and iii) the impact of interest from derivatives associated with notes payable, which is reclassified to interest expense as a component of total adjusted expenses. The Company considers adjusted net investment gains and losses important as it represents the remainder amount that is considered outside management’s control, while excluding the components that are within management’s control and are accordingly reclassified to net investment income and interest expense. The most comparable U.S. GAAP financial measure for adjusted net investment gains and losses is net investment gains and losses.

1    Prior period foreign currency impact reflected as “N/A” to isolate change for current period only.

2    Amounts excluding current period foreign currency impact are computed using the average foreign currency exchange rate for the comparable prior-year period, which eliminates fluctuations driven solely by foreign currency exchange rate changes.

1    Prior period foreign currency impact reflected as “N/A” to isolate change for current period only.

2    Amounts excluding current period foreign currency impact are computed using the average foreign currency exchange rate for the comparable prior-year period, which eliminates fluctuations driven solely by foreign currency exchange rate changes.

1    Amounts are included with interest expenses that are a component of adjusted expenses.

1    Amounts are included with interest expenses that are a component of adjusted expenses.

1    U.S. GAAP ROE is calculated by dividing net earnings (annualized) by average shareholders' equity.

2    See separate reconciliation of net income to adjusted earnings.

3    Impact of gains/losses associated with foreign currency remeasurement is calculated by restating excluding the cumulative [beginning January 1, 2021] foreign currency gains/losses associated with i) foreign currency remeasurement and ii) sales and redemptions of invested assets. The impact is the difference of adjusted return on equity - reported compared with adjusted return on equity, excluding from shareholders' equity, gains/losses associated with foreign currency remeasurement.

1    U.S. GAAP ROE is calculated by dividing net earnings (annualized) by average shareholders' equity.

2    See separate reconciliation of net income to adjusted earnings.

3    Impact of gains/losses associated with foreign currency remeasurement is calculated by restating excluding the cumulative [beginning January 1, 2021] foreign currency gains/losses associated with i) foreign currency remeasurement and ii) sales and redemptions of invested assets. The impact is the difference of adjusted return on equity - reported compared with adjusted return on equity, excluding from shareholders' equity, gains/losses associated with foreign currency remeasurement.

1Refer to previously defined adjusted earnings and adjusted earnings per diluted share.

2Amounts excluding currency changes were determined using the same foreign currency exchange rate for the current period as the comparable period in the prior year, which eliminates dollar-based fluctuations driven solely from currency rate changes.

3Net of reinsurance

4Refer to previously defined adjusted net investment income.

1Refer to previously defined adjusted earnings and adjusted earnings per diluted share.

2Amounts excluding currency changes were determined using the same foreign currency exchange rate for the current period as the comparable period in the prior year, which eliminates dollar-based fluctuations driven solely from currency rate changes.

3Net of reinsurance

4Refer to previously defined adjusted net investment income.

Analyst and investor contact - David A. Young, 706.596.3264; 800.235.2667 or dyoung@aflac.com

Media contact - Ines Gutzmer, 762.207.7601 or igutzmer@aflac.com

This document is a statistical supplement to Aflac’s quarterly earnings release. Throughout the presentation, amounts presented may not foot due to rounding. As you review the supplement, please note the non-U.S. GAAP financial measures and definitions found at the back of this document.

The Company adopted the Financial Accounting Standards Board’s Accounting Standard Update 2018-12 Financial Services - Insurance: Targeted Improvements to the Accounting for Long-Duration Contracts, as clarified and amended by (i) ASU 2019-09 Financial Services - Insurance: Effective Date, and (ii) ASU 2020-11 Financial Services - Insurance: Effective Date and Early Application (collectively, “LDTI”) as of January 1, 2023. The amended guidance is applied as of the beginning of the earliest period presented in the Company’s quarterly and annual financial statements, which results in a January 1, 2021 Transition Date. In conjunction with the adoption of LDTI, the Company changed its practice of recording the change in the deferred profit liability (DPL) on products with limited-payment features from the benefits and claims, net line item to the net earned premiums line item in the consolidated statement of earnings. This change in presentation has no impact on net earnings. All quarterly and annual amounts for 2021 and 2022 presented herein reflect these changes for LDTI and DPL.

(1) Includes previously owned shares used to purchase options (swapped shares) and/or shares purchased for deferred compensation program